These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4038579)

  • 1. Aztreonam plus clindamycin as therapy for pelvic infections in women.
    Pastorek JG; Cole C; Aldridge KE; Crapanzano JC
    Am J Med; 1985 Feb; 78(2A):47-50. PubMed ID: 4038579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aztreonam versus gentamicin, each with clindamycin, in the treatment of endometritis.
    Gibbs RS; Blanco JD; Lipscomb KA; St Clair PJ
    Obstet Gynecol; 1985 Jun; 65(6):825-9. PubMed ID: 3889748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overall clinical experience with aztreonam in the treatment of obstetric-gynecologic infections.
    Henry SA
    Rev Infect Dis; 1985; 7 Suppl 4():S703-8. PubMed ID: 3909327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with cefotaxime in obstetric and gynecologic infections.
    Hemsell DL; Cunningham FG; Nolan CM; Miller TT
    Rev Infect Dis; 1982; 4 Suppl():S432-8. PubMed ID: 6294795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute pelvic inflammatory disease with aztreonam, a new monocyclic beta-lactam antibiotic, and clindamycin.
    Dodson MG; Faro S; Gentry LO
    Obstet Gynecol; 1986 May; 67(5):657-62. PubMed ID: 3083313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperacillin versus clindamycin plus gentamicin for pelvic infections.
    Gilstrap LC; Maier RC; Gibbs RS; Connor KD; St Clair PJ
    Obstet Gynecol; 1984 Dec; 64(6):762-6. PubMed ID: 6504420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aztreonam plus clindamycin vs. tobramycin plus clindamycin for the treatment of intraabdominal infections.
    Birolini D; Moraes MF; de Souza OS
    Rev Infect Dis; 1985; 7 Suppl 4():S724-8. PubMed ID: 3909330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The polymicrobial etiology of acute pelvic inflammatory disease and treatment regimens.
    Dodson MG; Faro S
    Rev Infect Dis; 1985; 7 Suppl 4():S696-702. PubMed ID: 3909326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibiotic therapy in the treatment of inflammatory diseases in the minor pelvis].
    Vasiljević M; Marković A; Ganović R; Jovanović R
    Srp Arh Celok Lek; 1996; 124(7-8):193-6. PubMed ID: 9102846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection. The Piperacillin/tazobactam Study Group.
    Sweet RL; Roy S; Faro S; O'Brien WF; Sanfilippo JS; Seidlin M
    Obstet Gynecol; 1994 Feb; 83(2):280-6. PubMed ID: 8290195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology and management of postcesarean endomyometritis.
    Duff P
    Obstet Gynecol; 1986 Feb; 67(2):269-76. PubMed ID: 3511414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of aztreonam plus clindamycin with tobramycin plus clindamycin in the treatment of intra-abdominal infections.
    Birolini D; Moraes MF; de Souza OS
    Chemotherapy; 1989; 35 Suppl 1():49-57. PubMed ID: 2659290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of aztreonam versus tobramycin for aerobic gram-negative bacilli lower respiratory tract infections.
    Rodriguez JR; Ramirez-Ronda CH
    Am J Med; 1985 Feb; 78(2A):42-3. PubMed ID: 4038578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of a combination therapy with aztreonam and clindamycin for severe infections in leukemia and related disorders].
    Tsuda S; Tanaka S; Nakagawa H; Nishigaki H; Okuda T; Horiike S; Taniwaki M; Misawa S; Inazawa J; Abe T
    Jpn J Antibiot; 1989 Sep; 42(9):1926-37. PubMed ID: 2810755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clindamycin in the treatment of obstetric and gynecologic infections: a review.
    Zambrano D
    Clin Ther; 1991; 13(1):58-80. PubMed ID: 2029726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cefoxitin and clindamycin-gentamicin for pelvic infections.
    Larsen JW; Voise CT; Grossman JH
    Clin Ther; 1986; 9(1):77-83. PubMed ID: 3815461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of parenteral ciprofloxacin with clindamycin-gentamicin in the treatment of pelvic infection.
    Apuzzio JJ; Stankiewicz R; Ganesh V; Jain S; Kaminski Z; Louria D
    Am J Med; 1989 Nov; 87(5A):148S-151S. PubMed ID: 2589359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moxalactam for obstetric and gynecologic infections. In vitro and dose-finding studies.
    Cunningham FG; Hemsell DL; DePalma RT; Kappus S; Roark M; Nobles B
    Am J Obstet Gynecol; 1981 Apr; 139(8):915-21. PubMed ID: 6452816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of serious gram-negative infections with aztreonam.
    Greenberg RN; Reilly PM; Luppen KL; McMillian R; Bollinger M; Wolk SM; Darji TB; Noorani AA
    J Infect Dis; 1984 Nov; 150(5):623-30. PubMed ID: 6541672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter study comparing intravenous meropenem with clindamycin plus gentamicin for the treatment of acute gynecologic and obstetric pelvic infections in hospitalized women.
    Hemsell DL; Martens MG; Faro S; Gall S; McGregor JA
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S222-30. PubMed ID: 9126697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.